Ropes & Gray advised FogPharma on the transaction. FogPharma announced a collaboration with ARTBIO Inc. to co-develop new radiopharmaceuticals that would use FogPharma’s Helicon peptides platform,...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here